Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2026-01-29 00:00:00 ET · period of report 2026-01-27 · accession 0001193125-26-029599 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-29 | 2026-01-28 | KPTI | Abate Kristin | CAO | S - Sale | $7.03 | -50 | 22.6K | -0.2% | -$351.50 | |
| 2026-01-29 | 2026-01-27 | KPTI | Abate Kristin | CAO | A - Grant | $0.00 | +92 | 22.7K | +0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-28 | S | D | 50 | $7.03 | 22,622 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-27 | A | A | 92 | $0.00 | 22,672 | D | — | — | (F1) Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2023 that have been earned based on the level of achievement of the revenue and total shareholder return milestones as certified by the issuer's Compensation Committee on January 27, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on January 27, 2026. |